Home/Filings/4/0001415889-22-012077
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-22-012077

CIK 0001583107other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 5:59 PM ET

Size

4.5 KB

Accession

0001415889-22-012077

Insider Transaction Report

Form 4
Period: 2022-12-01
GRAHAM RICHARD A
SVP, Development
Transactions
  • Sale

    Ordinary Shares

    2022-12-01$10.73/sh2,084$22,361313,520 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:59 PM ET
Size
4.5 KB